69449 Sigma-AldrichBL21 Competent Cells - Novagen
BL21 host strain is the most widely used host background and has the advantage of being deficient in both lon and ompT proteases.
More>> BL21 host strain is the most widely used host background and has the advantage of being deficient in both lon and ompT proteases. Less<<BL21 Competent Cells - Novagen: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
Empfohlene Produkte
Übersicht
| Replacement Information |
|---|
Preis & Verfügbarkeit
| Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
|---|---|---|---|---|---|---|
| 69449-3 |
|
Kst.-Ampulle | 0.4 ml |
|
— |
| Description | |
|---|---|
| Overview | BL21 is the most widely used host background and has the advantage of being deficient in both lon (1) and ompT proteases. |
| This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com. |
|
| Catalogue Number | 69449 |
| Brand Family | Novagen® |
| References | |
|---|---|
| References | 1. Phillips, T. A., Van Bogelen, R. A., and Neidhardt, F. C. (1984) J. Bacteriol. 159, 283–287. |
| Product Information | |
|---|---|
| Components | |
| Guaranteed efficiency | Guaranteed efficiency: > 2 x 10⁷ cfu/μg |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information |
|---|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Storage and Shipping Information | |
|---|---|
| Ship Code | Dry Ice Only |
| Toxicity | Multiple Toxicity Values, refer to MSDS |
| Storage | ≤ -70°C |
| Avoid freeze/thaw | Avoid freeze/thaw |
| Do not freeze | Ok to freeze |
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN |
| 69449-3 | 04055977274318 |
Documentation
BL21 Competent Cells - Novagen SDB
| Titel |
|---|
BL21 Competent Cells - Novagen Analysenzertifikate
| Titel | Chargennummer |
|---|---|
| 69449 |
Literatur
| Übersicht |
|---|
| 1. Phillips, T. A., Van Bogelen, R. A., and Neidhardt, F. C. (1984) J. Bacteriol. 159, 283–287. |
Broschüre
| Titel |
|---|
| Competent Cell Brochure |
Literaturstellen
| Titel | |
|---|---|
|
|
Anwendungsvorschriften
| Titel |
|---|
| TB009 Competent Cells |